Proposals for standardized Protocols for cytogenetic analyses of acute leukemias, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes

Claudia Haferlach; Harald Rieder; Debra M. Lillington; Nicole Dastugue; Anne Hagemeijer; Jochen Harbott; Stephan Stilgenbauer; Sakari Knuutila; Bertil Johansson; Christa Fonatsch

doi:10.1002/gcc.20433

Proposals for standardized Protocols for cytogenetic analyses of acute leukemias, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes

Claudia Haferlach, Harald Rieder, Debra M. Lillington, Nicole Dastugue, Anne Hagemeijer, Jochen Harbott, Stephan Stilgenbauer, Sakari Knuutila, Bertil Johansson, Christa Fonatsch

Division of Clinical Genetics

Research output: Contribution to journal › Article › peer-review

Abstract

The impact of cytogenetic characterization based on chromosome banding analyses and fluorescence in situ hybridization on clinical decision making has increased dramatically during recent years. Therefore, laboratory techniques have to be optimized to provide reliable results for optimal patient care. In addition, quick and correct results save time and money by preventing unnecessary additional diagnostics and suboptimal treatment approaches. It was our aim to present proposals for standardized protocols to improve the diagnosis, and hence the treatment outcome, of hematologic malignancies.

Original language	English
Pages (from-to)	494-499
Journal	Genes, Chromosomes and Cancer
Volume	46
Issue number	5
DOIs	https://doi.org/10.1002/gcc.20433
Publication status	Published - 2007

Subject classification (UKÄ)

Medical Genetics and Genomics (including Gene Therapy)

Access to Document

10.1002/gcc.20433

Fingerprint

Dive into the research topics of 'Proposals for standardized Protocols for cytogenetic analyses of acute leukemias, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes'. Together they form a unique fingerprint.

Cite this

Haferlach, C., Rieder, H., Lillington, D. M., Dastugue, N., Hagemeijer, A., Harbott, J., Stilgenbauer, S., Knuutila, S., Johansson, B., & Fonatsch, C. (2007). Proposals for standardized Protocols for cytogenetic analyses of acute leukemias, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes. Genes, Chromosomes and Cancer, 46(5), 494-499. https://doi.org/10.1002/gcc.20433

@article{242489d125884a50b66d18ef78687228,

title = "Proposals for standardized Protocols for cytogenetic analyses of acute leukemias, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes",

abstract = "The impact of cytogenetic characterization based on chromosome banding analyses and fluorescence in situ hybridization on clinical decision making has increased dramatically during recent years. Therefore, laboratory techniques have to be optimized to provide reliable results for optimal patient care. In addition, quick and correct results save time and money by preventing unnecessary additional diagnostics and suboptimal treatment approaches. It was our aim to present proposals for standardized protocols to improve the diagnosis, and hence the treatment outcome, of hematologic malignancies.",

author = "Claudia Haferlach and Harald Rieder and Lillington, {Debra M.} and Nicole Dastugue and Anne Hagemeijer and Jochen Harbott and Stephan Stilgenbauer and Sakari Knuutila and Bertil Johansson and Christa Fonatsch",

year = "2007",

doi = "10.1002/gcc.20433",

language = "English",

volume = "46",

pages = "494--499",

journal = "Genes, Chromosomes and Cancer",

issn = "1045-2257",

publisher = "Wiley-Liss Inc.",

number = "5",

}

Haferlach, C, Rieder, H, Lillington, DM, Dastugue, N, Hagemeijer, A, Harbott, J, Stilgenbauer, S, Knuutila, S, Johansson, B & Fonatsch, C 2007, 'Proposals for standardized Protocols for cytogenetic analyses of acute leukemias, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes', Genes, Chromosomes and Cancer, vol. 46, no. 5, pp. 494-499. https://doi.org/10.1002/gcc.20433

Proposals for standardized Protocols for cytogenetic analyses of acute leukemias, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes. / Haferlach, Claudia; Rieder, Harald; Lillington, Debra M. et al.
In: Genes, Chromosomes and Cancer, Vol. 46, No. 5, 2007, p. 494-499.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Proposals for standardized Protocols for cytogenetic analyses of acute leukemias, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes

AU - Haferlach, Claudia

AU - Rieder, Harald

AU - Lillington, Debra M.

AU - Dastugue, Nicole

AU - Hagemeijer, Anne

AU - Harbott, Jochen

AU - Stilgenbauer, Stephan

AU - Knuutila, Sakari

AU - Johansson, Bertil

AU - Fonatsch, Christa

PY - 2007

Y1 - 2007

N2 - The impact of cytogenetic characterization based on chromosome banding analyses and fluorescence in situ hybridization on clinical decision making has increased dramatically during recent years. Therefore, laboratory techniques have to be optimized to provide reliable results for optimal patient care. In addition, quick and correct results save time and money by preventing unnecessary additional diagnostics and suboptimal treatment approaches. It was our aim to present proposals for standardized protocols to improve the diagnosis, and hence the treatment outcome, of hematologic malignancies.

AB - The impact of cytogenetic characterization based on chromosome banding analyses and fluorescence in situ hybridization on clinical decision making has increased dramatically during recent years. Therefore, laboratory techniques have to be optimized to provide reliable results for optimal patient care. In addition, quick and correct results save time and money by preventing unnecessary additional diagnostics and suboptimal treatment approaches. It was our aim to present proposals for standardized protocols to improve the diagnosis, and hence the treatment outcome, of hematologic malignancies.

U2 - 10.1002/gcc.20433

DO - 10.1002/gcc.20433

M3 - Article

SN - 1045-2257

VL - 46

SP - 494

EP - 499

JO - Genes, Chromosomes and Cancer

JF - Genes, Chromosomes and Cancer

IS - 5

ER -